Kansas Bioscience Park Venture Accelerator

KC’s newest venture capital firm invests locally - Kansas City Business Journal Leawood-based Flyover Capital made its first investment in a locally based company, participating in a $3.7 million investment in Olathe-based Innara Health.

Please join us in welcoming IntelligeneDX as a new Venture Accelerator tenant. IntelligeneDX is a genomic laboratory specialized in molecular analysis and development of molecular tests to diagnose, treat and prognosticate all types of cancer.

Now Accepting 2015 Iron Paw Award Nominations On behalf of the Kansas City Animal Health Corridor Advisory Board, it is my pleasure to invite you to submit your nominations for the 2015 KC Animal Health Corridor Iron Paw award. The Iron Paw award is given to an individual from research, academia, industry or government, regardless of title, wh…

The Kansas Bioscience Authority together with the KC Animal Health Corridor is pleased to join Advanced Animal Diagnostics (AAD) in the recent announcement that the company closed a $15 million Series C round of equity financing.

AAD presented in 2009 and 2011 at the KC Animal Health Investment Forum, a global event that has helped early and mid-stage animal health companies raise more than $150 million over the past six years.

AAD develops on-farm diagnostic technologies that change the way livestock producers manage animal health and costly diseases. The company expects to advance the development of additional livestock tests for dairy and beef markets, invest in production and manufacturing, and expand commercial efforts for new and existing customers with this financing. AAD plans to conduct limited product development research with the Kansas State Veterinary Diagnostics Lab in Manhattan, is working with a Lenexa manufacturer to make components of the Qscout Lab, and plans to establish a sales office in Western Kansas to support its current dairy product and future feedlot products.

The financing was co-led by the Kansas Bioscience Authority and Cultivian Sandbox, and included Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), Middleland Capital, and existing investors Intersouth Partners, Novartis Venture Funds and private individuals. The investment will allow AAD to accelerate the commercialization of its current product offering, QScout® MLD (milk leukocyte differential) test, while also expanding the company’s product line.

“Bringing AAD to the KC Animal Health Corridor positions Kansas as a growing dairy state, as well as an innovative state that is bringing new technologies to the dairy market,” said Tony Simpson, managing director, Kansas Bioscience Authority.

“The KC Animal Health Investment Forum showcases the most innovative companies in animal health today, and AAD is the second presenting company to receive KBA funding to date.”

Advanced Animal Diagnostics Closes $15 Million in Oversubscribed Series C Funding |... DURHAM, NC — December 8, 2014 — Advanced Animal Diagnostics (AAD) announced today the close of a $15 million Series C round of equity financing. The financing was co-led by Cultivian Sandbox and Kansas Bioscience Authority and included Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH…